Bioleap

About Bioleap

The company develops multi-modal therapies that integrate physics, biology, and AI to model and predict therapeutic responses in complex diseases. This platform accelerates the discovery and development of new biologics for researchers in the immuno-oncology market.

What does Bioleap do?

The company develops multi-modal therapies that integrate physics, biology, and AI to model and predict therapeutic responses in complex diseases. This platform accelerates the discovery and development of new biologics for researchers in the immuno-oncology market.

Where is Bioleap located?

Bioleap is based in Cambridge, United Kingdom.

When was Bioleap founded?

Bioleap was founded in 2022.

How much funding has Bioleap raised?

Bioleap has raised 390000.

Who founded Bioleap?

Bioleap was founded by Jacob Halatek.

  • Jacob Halatek - Founder/Innovation Leader
Location
Cambridge, United Kingdom
Founded
2022
Funding
390000
Employees
2 employees
Looking for specific startups?
Try our free semantic startup search

Bioleap

Score: 32/100
AI-Generated Company Overview (experimental) – could contain errors

Executive Summary

The company develops multi-modal therapies that integrate physics, biology, and AI to model and predict therapeutic responses in complex diseases. This platform accelerates the discovery and development of new biologics for researchers in the immuno-oncology market.

bioleap.ai100+
Founded 2022Cambridge, United Kingdom

Funding

$

Estimated Funding

$390K+

Team (<5)

Jacob Halatek

Founder/Innovation Leader

Bioleap - Funding: $300K+ | StartupSeeker